AWS
ZSAN

AJ Wealth Strategies’s Zosano Pharma Corporation ZSAN Stock Holding History

AJ Wealth Strategies’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,899
Closed -$221K – 254
2020
Q3 		$221K Buy
+3,899
New +$182K 0.02% 196

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AJ Wealth Strategies's ZSAN Position: Q4 2020 in Review

AJ Wealth Strategies sold out of Zosano Pharma Corporation (ZSAN) in Q4 2020, closing a stake of 3,899 shares — an estimated $221K sold.

AJ Wealth Strategies first reported a position in ZSAN in Q3 2020 and held it in 1 quarter. The position peaked at $221K in Q3 2020. 34 funds tracked by Wall St. Rank hold ZSAN as of Q4 2020.

  • AJ Wealth Strategies reported no remaining Zosano Pharma Corporation position as of Q4 2020 after selling out during the quarter.
  • AJ Wealth Strategies sold 3,899 Zosano Pharma Corporation shares in Q4 2020, an estimated $221K.
  • AJ Wealth Strategies first reported a position in Zosano Pharma Corporation in Q3 2020 and held it in 1 quarter.
  • AJ Wealth Strategies's Zosano Pharma Corporation position peaked at $221K in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q4 2020.

Based on AJ Wealth Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.